functional medicine and nutritional genomics - American Association ...
functional medicine and nutritional genomics - American Association ...
functional medicine and nutritional genomics - American Association ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
AAPI’S NUTRITION GUIDE TO OPTIMAL HEALTH: USING PRINCIPLES OF FUNCTIONAL MEDICINE AND NUTRITIONAL GENOMICS<br />
Dr. Hyman graduated with a B.A. from Cornell<br />
University, <strong>and</strong> graduated magna cum laude<br />
degree from the Ottawa University School of<br />
Medicine. He completed his residency at University<br />
of San Francisco's program in Family Medicine at<br />
the Community Hospital of Santa Rosa.<br />
Contact Mark Hyman at info@drhyman.com or<br />
413-637-9991.<br />
References:<br />
i<br />
http://www.cdc.gov/obesity/index.html<br />
ii<br />
Flegal KM, Carroll MD, Ogden CL, Curtin LR.<br />
Prevalence <strong>and</strong> trends in obesity among US adults,<br />
1999-2008. JAMA. 2010 Jan 20;303(3):235-<br />
41.<br />
iii<br />
Hedley AA, Ogden CL, Johnson CL, Carroll MD,<br />
Curtin LR, Flegal KM. Prevalence of overweight<br />
<strong>and</strong> obesity among US children, adolescents, <strong>and</strong><br />
adults, 1999-2002. JAMA. 2004 Jun<br />
16;291(23):2847-50.<br />
iv<br />
Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J,<br />
Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L,<br />
Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G,<br />
He J; China National Diabetes <strong>and</strong> Metabolic<br />
Disorders Study Group. Prevalence of diabetes<br />
among men <strong>and</strong> women in China. N Engl J Med.<br />
2010 Mar 25;362(12):1090-101.<br />
v<br />
Olshansky SJ, Passaro DJ, Hershow RC, Layden<br />
J, Carnes BA, Brody J, Hayflick L, Butler RN,<br />
Allison DB, Ludwig DS. A potential decline in life<br />
expectancy in the United States in the 21st century.<br />
N Engl J Med. 2005 Mar 17;352(11):1138-45.<br />
vi<br />
Bibbins-Domingo K, Coxson P, Pletcher MJ,<br />
Lightwood J, Goldman L. Adolescent overweight <strong>and</strong><br />
future adult coronary heart disease. N Engl J Med.<br />
2007 Dec 6;357(23):2371-9.<br />
vii<br />
Lakka HM, Laaksonen DE, Lakka TA, Niskanen<br />
LK, Kumpusalo E, Tuomilehto J, Salonen JT. The<br />
metabolic syndrome <strong>and</strong> total <strong>and</strong> cardiovascular<br />
disease mortality in middle-aged men. JAMA. 2002<br />
Dec 4;288(21):2709-16.<br />
viii<br />
Ott A, Stolk RP, van Harskamp F, Pols HA,<br />
Hofman A, Breteler MM. Diabetes mellitus <strong>and</strong> the<br />
risk of dementia: The Rotterdam Study. Neurology.<br />
1999 Dec 10;53(9):1937-42.<br />
ix<br />
Key TJ, Spencer EA, Reeves GK. Symposium 1:<br />
Overnutrition: consequences <strong>and</strong> solutions for obesity<br />
<strong>and</strong> cancer risk. Proc Nutr Soc. 2009 Dec 3:1-5.<br />
x<br />
http://apps.nccd.cdc.gov/DDTSTRS/FactSheet.aspx<br />
(National Diabetes Fact Sheet 2007).<br />
53<br />
xi<br />
Franks PW, Hanson RL, Knowler WC, Sievers<br />
ML, Bennett PH, Looker HC. Childhood obesity,<br />
other cardiovascular risk factors, <strong>and</strong> premature<br />
death. N Engl J Med. 2010 Feb 11;362(6):485-<br />
93.<br />
xii<br />
Action to Control Cardiovascular Risk in Diabetes<br />
Study Group, Gerstein HC, Miller ME, Byington RP,<br />
Goff DC Jr, Bigger JT, Buse JB, Cushman WC,<br />
Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield<br />
JL, Simons-Morton DG, Friedewald WT. Effects of<br />
intensive glucose lowering in type 2 diabetes. N<br />
Engl J Med. 2008 Jun 12;358(24):2545-59.<br />
xiii<br />
The ACCORD Study Group. Effects of combination<br />
lipid therapy in type 2 diabetes mellitus. N Engl J<br />
Med 2010.<br />
xiv<br />
The NAVIGATOR Study Group. Effect of<br />
nateglinide on the incidence of diabetes <strong>and</strong><br />
cardiovascular events. N Engl J Med 2010.<br />
xv<br />
The ACCORD Study Group. Effects of intensive<br />
blood-pressure control in type 2 diabetes mellitus. N<br />
Engl J Med 2010.<br />
xvi<br />
BARI 2D Study Group, Frye RL, August P,<br />
Brooks MM, Hardison RM, Kelsey SF, MacGregor<br />
JM, Orchard TJ, Chaitman BR, Genuth SM,<br />
Goldberg SH, Hlatky MA, Jones TL, Molitch ME,<br />
Nesto RW, Sako EY, Sobel BE. A r<strong>and</strong>omized trial<br />
of therapies for type 2 diabetes <strong>and</strong> coronary<br />
artery disease. N Engl J Med. 2009 Jun<br />
11;360(24):2503-15.<br />
xvii<br />
Teo KK, Sedlis SP, Boden WE, O'Rourke RA,<br />
Maron DJ, Hartigan PM, Dada M, Gupta V, Spertus<br />
JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman<br />
BR, Mancini GB, Weintraub WS; COURAGE Trial<br />
Investigators. Optimal medical therapy with or without<br />
percutaneous coronary intervention in older patients<br />
with stable coronary disease: a pre-specified subset<br />
analysis of the COURAGE (Clinical Outcomes<br />
Utilizing Revascularization <strong>and</strong> Aggressive druG<br />
Evaluation) trial. J Am Coll Cardiol. 2009 Sep<br />
29;54(14):1303-8.<br />
xviii<br />
<strong>American</strong> College of Preventive Medicine.<br />
Lifestyle Medicine—Evidence Review. June 30,<br />
2009. Available at:<br />
http://www.acpm.org/LifestyleMedicine.htm. Accessed<br />
September 18, 2009.<br />
xix<br />
Mozaffarian D, Wilson PW, Kannel WB. Beyond<br />
established <strong>and</strong> novel risk factors: lifestyle risk<br />
factors for cardiovascular disease. Circulation. 2008<br />
Jun 10;117(23):3031-8. Review.<br />
xx<br />
Yusuf S, Hawken S, Ounpuu S, et al;<br />
INTERHEART Study Investigators. Effect of<br />
2012